{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:40:00Z","timestamp":1780670400025,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jasc.2020.08.002","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T21:17:18Z","timestamp":1596748638000},"page":"197-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Review of SMARCA4 (BRG1)-deficient carcinomas following a malignant pleural effusion specimen confounded by reduced claudin-4 expression"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9924-837X","authenticated-orcid":false,"given":"Caroline A.","family":"Early","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3652-698X","authenticated-orcid":false,"given":"Sintawat","family":"Wangsiricharoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4833-6905","authenticated-orcid":false,"given":"Robert M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8822-5655","authenticated-orcid":false,"given":"Christopher J.","family":"VandenBussche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2020.08.002_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/jclinpath-2020-206451","article-title":"SMARCA family of genes","volume":"73","author":"Chetty","year":"2020","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/cas.13173","article-title":"Oncogenic roles of SMARCB1\/INI1 and its deficient tumors","volume":"108","author":"Kohashi","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jasc.2020.08.002_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/dc.24174","article-title":"A BAFfling liver aspirate: metastatic high grade SMARCA4 deficient undifferentiated gastroesophageal junction carcinoma masquerading as a hematolymphoid malignancy","volume":"47","author":"Kilic","year":"2019","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/modpathol.2015.155","article-title":"Loss of switch\/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas","volume":"29","author":"Karnezis","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.canlet.2018.01.046","article-title":"BAFfling pathologies: alterations of BAF complexes in cancer","volume":"419","author":"Arnaud","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jasc.2020.08.002_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/PAS.0000000000000558","article-title":"Loss of SMARCA4 expression is both sensitive and specific for the diagnosis of small cell carcinoma of ovary, hypercalcemic type","volume":"40","author":"Conlon","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/modpathol.2017.11","article-title":"Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities","volume":"30","author":"Yoshida","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.anndiagpath.2015.04.001","article-title":"Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant","volume":"19","author":"Strehl","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/PAT.0000000000000270","article-title":"SWI\/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma","volume":"47","author":"Stewart","year":"2015","journal-title":"Pathology"},{"key":"10.1016\/j.jasc.2020.08.002_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.anndiagpath.2016.10.006","article-title":"SMARCA4 and SMARCA2 deficiency in non\u2013small cell lung cancer: immunohistochemical survey of 316 consecutive specimens","volume":"26","author":"Herpel","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/PAS.0000000000001375","article-title":"SMARCA4-deficient uterine sarcoma and undifferentiated endometrial carcinoma are distinct clinicopathologic entities","volume":"44","author":"Kolin","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib18","first-page":"560","article-title":"Loss of BRG1\/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis","volume":"63","author":"Reisman","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.jasc.2020.08.002_bib39","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/PAS.0000000000001428","article-title":"SMARCA4-deficient sinonasal carcinoma: a series of 10 cases expanding the genetic spectrum of SWI\/SNF-driven sinonasal malignancies","volume":"44","author":"Agaimy","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/his.14117","article-title":"The clinicopathological and molecular analysis of gastric cancer with altered SMARCA4 expression","author":"Huang","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.jasc.2020.08.002_bib41","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000001508","article-title":"Recurrent Loss OF SMARCA4 in sinonasal teratocarcinosarcoma","author":"Rooper","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/his.14096","article-title":"Loss of switch\/sucrose non-fermenting complex protein expression in undifferentiated gastrointestinal and pancreatic carcinomas","volume":"77","author":"Tessier-Cloutier","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.jasc.2020.08.002_bib19","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ng.3399","article-title":"SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas","volume":"47","author":"Le Loarer","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jasc.2020.08.002_bib42","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/PGP.0000000000000449","article-title":"Undifferentiated endometrial carcinoma, an immunohistochemical study including PD-l1 testing of a series of cases from a single cancer center","volume":"37","author":"Al-Hussaini","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib43","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/modpathol.2017.61","article-title":"SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior","volume":"30","author":"Sauter","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00428-017-2148-5","article-title":"SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1neg\/CK7pos\/HepPar-1pos immunophenotype","volume":"471","author":"Agaimy A","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jasc.2020.08.002_bib45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/PAS.0000000000000787","article-title":"Rhabdoid and undifferentiated phenotype in renal cell carcinoma: analysis of 32 cases indicating a distinctive common pathway of dedifferentiation frequently associated with SWI\/SNF complex deficiency","volume":"41","author":"Agaimy","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib35","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/PAS.0000000000000554","article-title":"SWI\/SNF complex-deficient undifferentiated\/rhabdoid carcinomas of the gastrointestinal tract: A series of 13 cases highlighting mutually exclusive loss of SMARCA4 and SMARCA2 and frequent co-inactivation of SMARCB1 and SMARCA2","volume":"40","author":"Agaimy","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib11","article-title":"SMARCA4\/BRG1-deficient non-small cell lung carcinomas: a case series and review of the literature","volume":"1","author":"Nambirajan","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2020.08.002_bib12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00428-017-2148-5","article-title":"SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1neg\/CK7pos\/HepPar-1pos immunophenotype","volume":"471","author":"Agaimy","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jasc.2020.08.002_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jtho.2019.10.023","article-title":"SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas","volume":"15","author":"Rekhtman","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jasc.2020.08.002_bib14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000493335","article-title":"Cytologic features of SMARCA4-deficient thoracic sarcoma: a case report and comparison with other SWI\/SNF complex-deficient tumors","volume":"62","author":"Matsushita","year":"2018","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2020.08.002_bib15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000500684","article-title":"Genomic alterations in undifferentiated malignant tumors with rhabdoid phenotype and loss of BRG1 immunoexpression identified by fine needle aspirates","volume":"63","author":"Mei","year":"2019","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2020.08.002_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/dc.23904","article-title":"Cytological features of small cell carcinoma of the ovary-hypercalcemic type\/malignant ovarian rhabdoid tumor in ascitic fluid","volume":"46","author":"La\u00e9","year":"2018","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/cncy.20121","article-title":"Fine-needle aspiration of renal and extrarenal rhabdoid tumors\u00a0: The experience of the Institut Curie regarding 20 tumors in 13 patients","volume":"119","author":"Thomson","year":"2011","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/PAS.0000000000001188","article-title":"SMARCA4-deficient thoracic sarcomas","volume":"43","author":"Perret","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/LCTT.S186779","article-title":"Approaches to tumor classification in pulmonary sarcomatoid carcinoma","volume":"10","author":"Baldovini","year":"2019","journal-title":"Lung Cancer Targets Ther"},{"key":"10.1016\/j.jasc.2020.08.002_bib22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/cas.12065","article-title":"Lung cancer with loss of BRG1\/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features","volume":"104","author":"Matsubara","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jasc.2020.08.002_bib23","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1158\/1078-0432.CCR-15-1468","article-title":"SMARCA4\/BRG1 is a novel prognostic biomarker predictive of cisplatin-based chemotherapy outcomes in resected non-small cell lung cancer","volume":"22","author":"Bell","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jasc.2020.08.002_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/1066896919865944","article-title":"SMARCA4-deficient thoracic sarcoma: a case report and review of literature","volume":"28","author":"Stewart","year":"2020","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41467-019-08380-1","article-title":"SMARCA4 loss is synthetic lethal with CDK4\/6 inhibition in non-small cell lung cancer","volume":"10","author":"Xue","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jasc.2020.08.002_bib26","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/1759-7714.13215","article-title":"Exceptionally rapid response to pembrolizumab in a SMARCA4-deficient thoracic sarcoma overexpressing PD-L1: a case report","volume":"10","author":"Takada","year":"2019","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.jasc.2020.08.002_bib27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2217\/imt-2019-0142","article-title":"Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report","volume":"12","author":"Iijima","year":"2020","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jasc.2020.08.002_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/9403467","article-title":"SMARCA4-deficient carcinoma of unknown primary presenting with fatal paraneoplastic hypercalcemia in a heart transplant recipient: first report in a male patient","volume":"2017","author":"Agaimy","year":"2017","journal-title":"Case Rep Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.path.2018.10.006","article-title":"SWI\/SNF complex-deficient soft tissue neoplasms: a pattern-based approach to diagnosis and differential diagnosis","volume":"12","author":"Agaimy","year":"2019","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.jasc.2020.08.002_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/modpathol.2016.230","article-title":"Claudin-4 expression distinguishes SWI\/SNF complex-deficient undifferentiated carcinomas from sarcomas","volume":"30","author":"Schaefer","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/his.13525","article-title":"Frequent loss of claudin-4 expression in dedifferentiated and undifferentiated endometrial carcinomas","volume":"73","author":"Tessier-Cloutier","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.jasc.2020.08.002_bib32","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/PAS.0000000000000475","article-title":"SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas","volume":"39","author":"Karanian-Philippe","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrc3068","article-title":"SWI\/SNF nucleosome remodellers and cancer","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jasc.2020.08.002_bib36","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/s41379-018-0049-z","article-title":"SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma","volume":"31","author":"Kolin","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jasc.2020.08.002_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/cncy.21392","article-title":"Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology","volume":"122","author":"Jo","year":"2014","journal-title":"Cancer Cytopathol"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294520302672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294520302672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:47:31Z","timestamp":1761979651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294520302672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2213294520302672"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2020.08.002","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of SMARCA4 (BRG1)-deficient carcinomas following a malignant pleural effusion specimen confounded by reduced claudin-4 expression","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2020.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}